Dyngo-4a
(Synonyms: Dyngo-4a) 目录号 : GC17208
Dyngo-4a是一种强效的新型dynamin抑制剂，对DynI（脑源）、DynI（重组）和DynII（重组）的IC50分别为 0.38μM、1.1μM和2.3μM。
Cas No.:1256493-34-1
Sample solution is provided at 25 µL, 10mM.
_1-3.$$$39978408@51.jpg');)
_1-9.$$$38538795@65.jpg');)
_1-9.$$$39112701@51.jpg');)
_1-7.$$$37316672@70.jpg');)
_366-372.$$$36198801@70.jpg');)
.$$$38565142@65.jpg');)
_1867-1883.$$$33248023@67.jpg');)
_eads6055.$$$39977546@45.jpg');)
_eadm9805.$$$40080571@45.jpg');)
_eadj3020.$$$39666821@45.jpg');)
_1-20.$$$39757301@28.jpg');)
_1-24.$$$38898113@28.jpg');)
_273-287.$$$36806353@46.jpg');)
_1-16.$$$37156877@44.jpg');)
_1-19.$$$37460805@44.jpg');)
_1291-1307.$$$34518654@46.jpg');)
Dyngo-4a is a potent, novel dynamin inhibitor with IC50 values of 0.38μM, 1.1μM, and 2.3μM for DynI (brain), DynI (rec), and DynII (rec), respectively[1]. Dynamin is a large GTPase that hydrolyzes GTP to mediate membrane scission and serves as the key “membrane scissor” in clathrin-mediated endocytosis(CME)[2]. Dyngo-4a blocks the GTPase activity of dynamin, thereby inhibiting CME and is widely used to study mechanisms of neurotransmission, toxin uptake, and viral infection[3][4].
In vitro, treatment of Neuro-2a neuroblastoma cells with Dyngo-4a (10-30μM; 6 days) dose-dependently inhibited cells proliferation and induced their differentiation into Tuj-1-positive neuron-like cells, while markedly up-regulating p-AKT and p-ERK1/2 phosphorylation without affecting p-EGFR[5].
In vivo, Dyngo-4a (i.p.; 30mg/kg at 0h, then 30mg/kg at 4.5–8h (total 60mg/kg)) treatment suppressed BoNT/A-induced muscle paralysis at the rat hemidiaphragm and significantly delayed the onset of botulism in an in vivo murine model[6]. Dyngo-4a (30mg/kg; i.p.; administered on the day of infection) markedly alleviated rotavirus (RV)-induced diarrhea, reducing the diarrhea score from 1.0 to 0.2, while lowering the viral load in the small intestine by approximately 90% and substantially mitigating RV-triggered vacuolar degeneration of small-intestinal villous epithelial cells in 6–8-day-old BALB/c mice[7].
References:
[1] McCluskey A, Daniel JA, Hadzic G, et al. Building a better dynasore: the dyngo compounds potently inhibit dynamin and endocytosis. Traffic. 2013;14(12):1272-1289.
[2] Ferguson SM, De Camilli P. Dynamin, a membrane-remodelling GTPase. Nat Rev Mol Cell Biol. 2012 Jan 11;13(2):75-88.
[3] Ahmed A, Trezza A, Gentile M, et al. Dynamin-independent CaV1.2 and KCa1.1 channels regulation and vascular tone modulation by the mitochondrial fission inhibitors dynasore and dyngo-4a. Eur J Pharmacol. 2023;951:175786.
[4] Harper CB, Popoff MR, McCluskey A, Robinson PJ, Meunier FA. Targeting membrane trafficking in infection prophylaxis: dynamin inhibitors. Trends Cell Biol. 2013;23(2):90-101.
[5] Huang J, Zhou Y, Zeng S, et al. Dyngo-4a Induces Neuroblastoma Cell Differentiation Through The AKT and ERK1/2 Pathway. CNS Neurol Disord Drug Targets. 2023;22(10):1526-1534.
[6] Harper CB, Martin S, Nguyen TH, et al. Dynamin inhibition blocks botulinum neurotoxin type A endocytosis in neurons and delays botulism. J Biol Chem. 2011;286(41):35966-35976.
[7] Zhang Q, Zhang Q, Xu Z, et al. Dyngo-4a protects mice from rotavirus infection by affecting the formation of dynamin 2 oligomers. Sci Bull (Beijing). 2020;65(21):1796-1799.
Dyngo-4a是一种强效的新型dynamin抑制剂，对DynI（脑源）、DynI（重组）和DynII（重组）的IC50分别为 0.38μM、1.1μM和2.3μM [1]。Dynamin是一种大分子GTP酶，通过水解GTP介导膜切割，是网格蛋白介导内吞（CME）过程中的关键“膜剪切酶”[2]。Dyngo-4a通过阻断dynamin的GTP酶活性，抑制CME，被广泛用于研究神经传递、毒素摄取及病毒感染等机制[3][4]。
体外实验中，用10–30μM Dyngo-4a连续处理6天，可剂量依赖性地抑制Neuro-2a神经母细胞瘤细胞增殖，并诱导其分化为Tuj-1阳性神经元样细胞，同时显著上调p-AKT与p-ERK1/2水平，而p-EGFR无明显变化[5]。
体内实验中，Dyngo-4a（腹腔注射；0h给予30mg/kg，4.5–8h 追加30mg/kg，总剂量 60mg/kg）显著抑制大鼠半膈肌的BoNT/A诱导性肌麻痹，并在小鼠体内模型中明显延迟肉毒中毒发作[6]。以 30mg/kg Dyngo-4a（感染当日腹腔注射一次）可明显缓解6–8日龄BALB/c小鼠轮状病毒（RV）所致腹泻，使腹泻评分由1.0 降至0.2，同时将小肠病毒载量降低约90%，并显著减轻RV引起的小肠绒毛上皮细胞空泡变性[7]。
| Cell experiment [1]: | |
Cell lines | Neuro-2a mouse neuroblastoma cells |
Preparation Method | Neuro-2a mouse neuroblastoma cells were maintained in MEM supplemented with 10% FBS, streptomycin (100µg/ml), penicillin (100U/ml), GlutaMAX (1mM), and sodium pyruvate (1mM) in a humidified incubator (5% CO2) at 37°C. For the induction of neuronal differentiation, the Neuro-2a cells were seeded in maintained medium overnight and then incubated in a control medium (supplemented with 2% FBS), and differentiated with 30µM Dyngo-4a for 6 days. The Dyngo-4a was dissolved in DMSO and diluted as needed immediately prior to use. Cell images were captured by the optical microscope. |
Reaction Conditions | 30μM; 6 days |
Applications | Dyngo-4a inhibited cells proliferation and induced their differentiation. |
| Animal experiment [2]: | |
Animal models | Female CD-1 mice |
Preparation Method | BoNT/A was diluted in 0.9% saline containing 0.1mg/ml BSA, immediately prior to use. Female CD-1 mice (30– 40g) were injected intraperitoneally with 1mg of Dyngo-4a (which is 30mg/kg body weight) or vehicle (1/9 NMP/PEG300 (1 part NMP to 9 parts PEG300) in PBS). 1.5–2h later, mice were injected with 2LD50BoNT/A via the tail vein. A top-up of 1mg of Dyngo-4a or vehicle was administered 4.5–8h after the initial intraperitoneal injection. Mice were constantly monitored for signs of botulism and euthanized upon development of acute respiratory distress. |
Dosage form | i.p.; 30mg/kg at 0h, then 30mg/kg at 4.5–8h (total 60mg/kg) |
Applications | Dyngo-4a treatment significantly delayed the onset of botulism. |
References: | |
| Cas No. | 1256493-34-1 | SDF | |
| 别名 | Dyngo-4a | ||
| 化学名 | (E)-N'-(2,3,4,5-tetrahydroxybenzylidene)-2-naphthohydrazide | ||
| Canonical SMILES | O=C(C1=CC=C2C=CC=CC2=C1)N/N=C/C3=CC(O)=C(O)C(O)=C3O | ||
| 分子式 | C18H14N2O5 | 分子量 | 338.31 |
| 溶解度 | ≥ 33.8mg/mL in DMSO | 储存条件 | Store at -20°C |
| General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液；一旦配成溶液，请分装保存，避免反复冻融造成的产品失效。 储备液的保存方式和期限：-80°C 储存时，请在 6 个月内使用，-20°C 储存时，请在 1 个月内使用。 为了提高溶解度，请将管子加热至37℃，然后在超声波浴中震荡一段时间。 |
||
| Shipping Condition | 评估样品解决方案：配备蓝冰进行发货。所有其他可用尺寸：配备RT，或根据请求配备蓝冰。 | ||
| 制备储备液 | |||
 |
1 mg | 5 mg | 10 mg |
| 1 mM | 2.9559 mL | 14.7793 mL | 29.5587 mL |
| 5 mM | 0.5912 mL | 2.9559 mL | 5.9117 mL |
| 10 mM | 0.2956 mL | 1.4779 mL | 2.9559 mL |
| 第一步：请输入基本实验信息（考虑到实验过程中的损耗，建议多配一只动物的药量） | ||||||||||
| 给药剂量 | mg/kg |  |
动物平均体重 | g | |
每只动物给药体积 | ul | |
动物数量 | 只 |
| 第二步：请输入动物体内配方组成（配方适用于不溶于水的药物；不同批次药物配方比例不同，请联系GLPBIO为您提供正确的澄清溶液配方） | ||||||||||
| % DMSO % % Tween 80 % saline | ||||||||||
| 计算重置 | ||||||||||
计算结果:
工作液浓度： mg/ml；
DMSO母液配制方法： mg 药物溶于 μL DMSO溶液（母液浓度 mg/mL，
体内配方配制方法：取 μL DMSO母液，加入 μL PEG300，混匀澄清后加入μL Tween 80，混匀澄清后加入 μL saline，混匀澄清。
1. 首先保证母液是澄清的；
2.
一定要按照顺序依次将溶剂加入，进行下一步操作之前必须保证上一步操作得到的是澄清的溶液，可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet